Visual acuity, endothelial cell density and polymegathism after iris-fixated lens implantation
Authors Nassiri N, Ghorbanhosseini S, Jafarzadehpur E, Kavousnezhad S, Nassiri N, Sheibani K
Received 19 November 2017
Accepted for publication 15 February 2018
Published 29 March 2018 Volume 2018:12 Pages 601—605
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 2
Editor who approved publication: Dr Scott Fraser
Nader Nassiri,1 Saeedeh Ghorbanhosseini,2 Ebrahim Jafarzadehpur,2 Sara Kavousnezhad,3 Nariman Nassiri,4 Kourosh Sheibani5
1Imam Hossein Medical Center, Shahid Beheshti University of Medical Science, Tehran, Iran; 2Department of Optometry, Iran University of Medical Sciences, Tehran, Iran; 3Vanak Eye Clinic, Tehran, Iran; 4Jules Stein Eye Institute, University of California at Los Angeles, Los Angeles, CA, USA; 5Basir Eye Health Research Center, Basir Eye Clinic, Tehran, Iran
Purpose: The purpose of this study was to evaluate the visual acuity as well as endothelial cell density (ECD) and polymegathism after iris-fixated lens (Artiflex® AC 401) implantation for correction of moderate to high myopia.
Patients and methods: In this retrospective cross-sectional study, 55 eyes from 29 patients undergoing iris-fixated lens implantation for correction of myopia (−5.00 to −15.00 D) from 2007 to 2014 were evaluated. Uncorrected visual acuity, best spectacle-corrected visual acuity, refraction, ECD and polymegathism (coefficient of variation [CV] in the sizes of endothelial cells) were measured preoperatively and 6 months postoperatively.
Results: In the sixth month of follow-up, the uncorrected vision acuity was 20/25 or better in 81.5% of the eyes. The best-corrected visual acuity was 20/30 or better in 96.3% of the eyes, and more than 92% of the eyes had a refraction score of ±1 D from the target refraction. The mean corneal ECD of patients before surgery was 2,803±339 cells/mm2, which changed to 2,744±369 cells/mm2 six months after surgery (p=0.142). CV in the sizes of endothelial cells before the surgery was 25.7%±7.1% and six months after surgery it was 25.9%±5.4% (p=0.857).
Conclusion: Artiflex iris-fixated lens implantation is a suitable and predictable method for correction of moderate to high myopia. There was no statistically significant change in ECD and polymegathism (CV in the sizes of endothelial cells) after 6 months of follow-up.
Keywords: cornea, endothelial cell, density, Artiflex, refractive surgery
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]